Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International Cash Flow Statement

Financials in millions USD. Fiscal year is December - November.

Year	2023	2022	2021	2020	2019
Net Income	-9.52	2.77	2.08	3.62	2.29
Depreciation & Amortization	1.71	1.81	1.33	0.64	0.4
Share-Based Compensation	0.82	0.46	0.3	0.62	0.4
Other Operating Activities	15.91	3.53	4.21	3.58	3.2
Operating Cash Flow	8.92	8.57	7.93	8.47	6.29
Operating Cash Flow Growth	4.05%	8.16%	-6.38%	34.50%	18.03%
Capital Expenditures	-6.84	-10.3	-1.84	-0.45	-0.66
Change in Investments	-0.51	0.02	0	0.81	0
Other Investing Activities	-0.8	-5	-5.11	-	-
Investing Cash Flow	-8.14	-15.28	-6.95	0.36	-0.66
Dividends Paid	0	-7.67	0	0	0
Share Issuance / Repurchase	-0.8	-1.27	1.03	0.04	-0.99
Debt Issued / Paid	-1.21	9.29	-4.1	-3.1	-4.1
Other Financing Activities	-0.07	-0.2	-	-1.95	-0.05
Financing Cash Flow	-2.07	0.15	-3.07	-5	-5.13
Net Cash Flow	-1.3	-6.56	-2.1	3.82	0.5
Free Cash Flow	2.08	-1.73	6.08	8.02	5.63
Free Cash Flow Growth	-	-	-24.14%	42.33%	20.17%
Free Cash Flow Margin	6.64%	-5.69%	21.05%	25.74%	17.70%
Free Cash Flow Per Share	0.25	-0.20	0.75	1.06	0.72

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).